Skip to main content

Peer Review reports

From: An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)

Original Submission
29 May 2023 Submitted Original manuscript
30 May 2023 Author responded Author comments - Carina Joy Donegan
Resubmission - Version 2
30 May 2023 Submitted Manuscript version 2
1 Jun 2023 Author responded Author comments - Carina Joy Donegan
Resubmission - Version 3
1 Jun 2023 Submitted Manuscript version 3
23 Jun 2023 Reviewed Reviewer Report - Declan McLoughlin
30 Jun 2023 Reviewed Reviewer Report - Paul Deslandes
24 Jul 2023 Author responded Author comments - Carina Joy Donegan
Resubmission - Version 4
24 Jul 2023 Submitted Manuscript version 4
23 Aug 2023 Reviewed Reviewer Report - Declan McLoughlin
24 Aug 2023 Reviewed Reviewer Report - Paul Deslandes
30 Aug 2023 Author responded Author comments - Carina Joy Donegan
Resubmission - Version 5
30 Aug 2023 Submitted Manuscript version 5
Publishing
13 Sep 2023 Editorially accepted
5 Oct 2023 Article published 10.1186/s40814-023-01399-8

You can find further information about peer review here.

Back to article page